Govt pays for deadly, unapproved drugs (Update)

November 23rd, 2008 By RICARDO ALONSO-ZALDIVAR and FRANK BASS , Associated Press Writers in Medicine & Health / Medications

Enlarge

Graphic shows some deadly drugs banned by the FDA.

(AP) -- Dozens of deaths have been linked to medications that have never been reviewed by the government for safety and effectiveness but are still covered under Medicaid, an Associated Press analysis of federal data has found.



Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .


Relevant stories

Rank Filter

Move the slider to adjust rank threshold, so that you can hide some of the comments.



  • DavidRochlin - Nov 24, 2008
    Does the Author then advocate a ban of asprin?
    This story lacks perspective. There are many drugs that predate any FDA approval process or FDA for that matter. Just as some herbal medicines used for thousands of years, may have real theraputic value, so do some of these unapproved drugs. Unapproved does not mean obsolete or bad. Furthermore, valuable patents are the only incentive for a drug manufacturer to spend hundreds of millions or billions on a drug approval process. Requiring one simply amounts to banning the drug. Who would pay $2 billion to try to get some niche drug, used by a few thousand eighty year olds, for 60 years, approved by the FDA?
    Should we be deprived of our own Western heritage of folk medicines?
    The fact is that the FDA drug approval process, sometimes better and sometimes worse, over the decades, is now more or less broken. Getting a drug approved is now prohibitively expensive, even for Pharm giants with expectations of lucrative patents. Little drugs like these, in the public domain, don't have a prayer of approval, regardless of efficacy.
  • bmcghie - Nov 24, 2008
    "Dozens of deaths have been linked to them. " So why should we care? I'm pretty sure you could save more lives spending this money elsewhere.
  • fleem - Nov 24, 2008
    The masses will see this in a headline and gasp, "Oh how horrible! There oughta be a law!".
  • Velanarris - Nov 24, 2008
    As is typical, the haves test their new and "dangerous" drugs on the have nots.

    Welcome to the world. Human trials start with the poorest, not the most affluent. When the drug is proven to work well and is valuable, the haves can afford the "safer" version, while the have-nots cannot afford it whatsoever.
  • richgibula - Nov 24, 2008
    Some of these drugs have been in use for a long time, probably longer than aspirin. Some do need to go, but some do not have a ready alternative, such as quinine. There are many people that have tried alternatives, but can't sleep due to their leg cramps.
Rating: 4/5 after 5 votes


Other News

'It takes 2 to know 1': Shared experiences change self-recognition

Medicine & Health / Psychology

created 17 hours ago | popularity 3 / 5 after 2 votes | comments 1

Looking at yourself in the mirror every morning, you never think to question whether the person you see is actually you. You feel familiar—at home with your own unique self image. After all, you have been sporting the same ...


Mountaineers measure lowest human blood oxygen levels on record

Medicine & Health / Research

created 9 hours ago | popularity 5 / 5 after 3 votes | comments no comments yet

The lowest ever levels of oxygen in humans have been reported in climbers on an expedition led by UCL (University College London) doctors. The world-first measurements of blood oxygen levels in climbers near the top of Mount ...


Studies examine genetic determinants of ADHD

Medicine & Health / Genetics

created 13 hours ago | popularity 4 / 5 after 1 vote | comments 2

A special issue of American Journal of Medical Genetics (AJMG): Part B: Neuropsychiatric Genetics presents a comprehensive overview of the latest progress in genetic research of Attention Deficit/Hyperactivity Disorder (ADHD) ...


Study: Excessive use of antiviral drugs could aid deadly flu

Medicine & Health / Research

created 13 hours ago | popularity not rated yet | comments no comments yet

Influenza's ability to resist the effects of cheap and popular antiviral agents in Asia and Russia should serve as a cautionary tale about U.S. plans to use the antiviral Tamiflu in the event of widespread ...


Scientists unravel structure of key breast cancer target enzyme

Medicine & Health / Cancer

created 13 hours ago | popularity not rated yet | comments no comments yet

The molecular details of Aromatase, the key enzyme required for the body to make estrogen, are no longer a mystery thanks to the structural biology work done by the Ghosh lab at the Hauptman-Woodward Medical ...